ES2646737T3 - Sistema terapéutico transdérmico para clorhidrato de ácido 5-aminolevulínico - Google Patents

Sistema terapéutico transdérmico para clorhidrato de ácido 5-aminolevulínico Download PDF

Info

Publication number
ES2646737T3
ES2646737T3 ES12750597.2T ES12750597T ES2646737T3 ES 2646737 T3 ES2646737 T3 ES 2646737T3 ES 12750597 T ES12750597 T ES 12750597T ES 2646737 T3 ES2646737 T3 ES 2646737T3
Authority
ES
Spain
Prior art keywords
acid hydrochloride
therapeutic system
transdermal therapeutic
aminolevulinic acid
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES12750597.2T
Other languages
English (en)
Inventor
Tobias Jung
Michael Horstmann
Gerd Hoffmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Photonamic GmbH and Co KG
Original Assignee
LTS Lohmann Therapie Systeme AG
Photonamic GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG, Photonamic GmbH and Co KG filed Critical LTS Lohmann Therapie Systeme AG
Application granted granted Critical
Publication of ES2646737T3 publication Critical patent/ES2646737T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Sistema terapéutico transdérmico que comprende una capa de respaldo que es impermeable al principio activo, una matriz polimérica y una capa protectora desprendible caracterizado porque el principio activo es clorhidrato de ácido 5-aminolevulínico, porque el polímero de base de la matriz polimérica es un poliacrilato adhesivo y porque el poliacrilato ha sido obtenido sin agente de reticulación.

Description

imagen1
imagen2
imagen3
imagen4
imagen5

Claims (1)

  1. imagen1
ES12750597.2T 2011-08-31 2012-08-24 Sistema terapéutico transdérmico para clorhidrato de ácido 5-aminolevulínico Active ES2646737T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102011111865 2011-08-31
DE102011111865A DE102011111865A1 (de) 2011-08-31 2011-08-31 Transdermales therapeutisches System für 5-Aminolävulinsäurehydrochlorid
PCT/EP2012/066541 WO2013030129A1 (de) 2011-08-31 2012-08-24 Transdermales therapeutisches system für 5-aminolävulinsäurehydrochlorid

Publications (1)

Publication Number Publication Date
ES2646737T3 true ES2646737T3 (es) 2017-12-15

Family

ID=46724447

Family Applications (1)

Application Number Title Priority Date Filing Date
ES12750597.2T Active ES2646737T3 (es) 2011-08-31 2012-08-24 Sistema terapéutico transdérmico para clorhidrato de ácido 5-aminolevulínico

Country Status (17)

Country Link
US (2) US10307382B2 (es)
EP (1) EP2750673B1 (es)
JP (2) JP6035335B2 (es)
KR (1) KR101933610B1 (es)
CN (1) CN103764135B (es)
AU (1) AU2012301042B2 (es)
BR (1) BR112014004635B1 (es)
CA (1) CA2844288C (es)
DE (1) DE102011111865A1 (es)
DK (1) DK2750673T3 (es)
ES (1) ES2646737T3 (es)
MX (1) MX351514B (es)
NO (1) NO2750673T3 (es)
PL (1) PL2750673T3 (es)
PT (1) PT2750673T (es)
RU (1) RU2607657C2 (es)
WO (1) WO2013030129A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9179844B2 (en) 2011-11-28 2015-11-10 Aranz Healthcare Limited Handheld skin measuring or monitoring device
EP3067050A1 (en) * 2015-03-13 2016-09-14 Acino AG Transdermal therapeutic system with an overtape comprising two adhesive layers
CZ307444B6 (cs) * 2015-04-22 2018-08-29 Jakub Rak Mukoadhezivní polymerní film pro fotosenzitivní terapii v ústní dutině s obsahem fotosenzitizérů
US10013527B2 (en) 2016-05-02 2018-07-03 Aranz Healthcare Limited Automatically assessing an anatomical surface feature and securely managing information related to the same
US11116407B2 (en) 2016-11-17 2021-09-14 Aranz Healthcare Limited Anatomical surface assessment methods, devices and systems
US11903723B2 (en) 2017-04-04 2024-02-20 Aranz Healthcare Limited Anatomical surface assessment methods, devices and systems
KR102171200B1 (ko) 2018-11-20 2020-10-28 제너럴바이오(주) 5-아미노레불린산 수화염화물과 그 유도체를 유효성분으로 함유하는 여드름성 피부염 개선 또는 그의 조성물
CN111517973B (zh) * 2019-02-02 2023-08-04 中国科学院天津工业生物技术研究所 一种从发酵液中制备5-氨基乙酰丙酸盐酸盐的生产工艺及其应用
US12039726B2 (en) 2019-05-20 2024-07-16 Aranz Healthcare Limited Automated or partially automated anatomical surface assessment methods, devices and systems
KR20250161695A (ko) * 2024-05-08 2025-11-18 정성희 광역학 치료용 용해성 마이크로니들 및 이의 제조방법

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996006602A1 (en) * 1993-08-27 1996-03-07 Noven Pharmaceuticals, Inc. COMPOSITIONS AND METHODS FOR THE ADMINISTRATION OF δ-AMINOLEVULINIC ACID AND PHARMACEUTICAL EQUIVALENTS THEREOF
TR199802659T2 (xx) 1996-06-20 1999-03-22 Lavipharm S.A. Topikal akne tedavisi i�in bir ara� ve tedavi y�ntemi.
GR1002807B (el) 1996-06-20 1997-11-13 Lavipharm A.E. Συστημα για την τοπικη θεραπεια της ακμης και μεθοδος παραγωγης του
US5856566A (en) * 1997-09-02 1999-01-05 Dusa Pharmaceuticals, Inc. Sterilized 5-aminolevulinic acid
ATE288256T1 (de) * 1999-01-14 2005-02-15 Noven Pharma Dermale zusammensetzungen
DE10034673C1 (de) * 2000-07-17 2002-04-25 Medac Klinische Spezialpraep Dermales Applikationssystem für Aminolävulinsäure und seine Verwendung
JP2004506005A (ja) * 2000-08-16 2004-02-26 ザ　ジェネラル　ホスピタル　コーポレイション　ディー　ビー　エイ　マサチューセッツ　ジェネラル　ホスピタル 尋常性挫瘡用の局所アミノレブリン酸−光力学的治療
KR100846912B1 (ko) 2001-01-12 2008-07-17 페데랄노에고수다르스트벤노에유니타르노에프레드프리야티에고수다르스트벤니나우쉬니티센트르나우쉬노이슬레도바텔스키인스티튜트오르가니쉐스키크흐포루프로두크토브아이크르아시텔에이에프지업지엔트스니오피크 광에너지 요법 및 그 요법을 수행하기 위한 도포기
RU2323017C2 (ru) * 2001-10-24 2008-04-27 Пауэр Пэйпер Лтд. Устройство и способ контролируемой доставки активных веществ в кожу
DE10200578A1 (de) 2002-01-09 2003-07-10 Roehm Gmbh Haft- und Bindemittel für dermale oder transdermale Therapiesysteme
DE10202487A1 (de) * 2002-01-23 2003-07-31 Photonamic Gmbh & Co Kg Dermales Applikationssystem für Aminolävulinsäure-Derivate
DE10344334A1 (de) 2003-09-24 2005-04-28 Johann Berger Gewebtes Gurtband
EP1847264B1 (en) * 2005-01-31 2017-05-03 Hisamitsu Pharmaceutical Co., Inc. Bisoprolol patch
US20060182790A1 (en) * 2005-02-17 2006-08-17 Flor Mayoral Dermal medicaments application enhancer
US20100087768A1 (en) * 2008-10-02 2010-04-08 Forlano Paula Transdermal drug delivery system for liquid active ingredient

Also Published As

Publication number Publication date
RU2607657C2 (ru) 2017-01-10
MX2014002215A (es) 2014-04-30
CN103764135A (zh) 2014-04-30
CN103764135B (zh) 2018-06-22
KR101933610B1 (ko) 2018-12-28
CA2844288C (en) 2019-08-20
KR20140056370A (ko) 2014-05-09
JP6035335B2 (ja) 2016-11-30
EP2750673A1 (de) 2014-07-09
WO2013030129A1 (de) 2013-03-07
NO2750673T3 (es) 2018-01-06
DE102011111865A1 (de) 2013-02-28
BR112014004635A2 (pt) 2017-03-14
JP2014527537A (ja) 2014-10-16
PL2750673T3 (pl) 2018-11-30
MX351514B (es) 2017-10-17
AU2012301042A1 (en) 2014-03-20
US20190240166A1 (en) 2019-08-08
CA2844288A1 (en) 2013-03-07
JP2017061489A (ja) 2017-03-30
BR112014004635B1 (pt) 2022-09-13
US10307382B2 (en) 2019-06-04
RU2014111255A (ru) 2015-10-10
DK2750673T3 (da) 2017-11-20
PT2750673T (pt) 2017-11-15
EP2750673B1 (de) 2017-08-09
JP6203364B2 (ja) 2017-09-27
US20140323994A1 (en) 2014-10-30
AU2012301042B2 (en) 2017-07-13

Similar Documents

Publication Publication Date Title
ES2543977T3 (es) Sistema terapéutico transdérmico para la administración del principio activo buprenorfina
ES2536206T3 (es) Parche medicinal
ES2502472T3 (es) Composición adhesiva para su uso en un inmunosensor
ES2496092T3 (es) El uso de amisulprida para tratar náuseas y vómitos posoperatorios
CL2014001450A1 (es) Forma de dosis de liberacion controlada solida que comprende un analgesico opioide dispersado en un material de matriz; metodo de preparacion; uso en el tratamiento del dolor.
ES2471951T3 (es) Procedimiento y dispositivo para el estampado en caliente
ES2523727T3 (es) Procedimiento y dispositivo para producir parche adhesivo
ES2581985T3 (es) Sistema terapéutico transdérmico que contiene norelgestromina para la contracepción y el reemplazo hormonal
ES2529464T3 (es) Lámina o cinta adhesiva sensible a la presión para aplicación cutánea y proceso para producir la misma
PE20151147A1 (es) Sistema de liberacion transdermica
MX2019001103A (es) Sistema de suministro transdermico de donepezilo.
ES2513691T3 (es) Preparación transdérmica
MX352795B (es) Sistema de administracion transdermica que comprende buprenorfina.
CL2012003281A1 (es) Uso de compuestos específicos estimuladores y/o activadores de sgc; formulacion farmaceutica que comprende dichos compuestos; kit que comprende los compuestos, y uso para la prevencion y/o tratamiento de la esclerosis sistematica.
BR112014004635A2 (pt) sistema terapêutico transdérmico para cloridrato de ácido 5-aminolavulínico
CL2013000424A1 (es) Forma de dosificacion farmaceutica resistente al rompimiento que comprende a) un ingrediente farmacologicamente activo, b) un polimero, c) un oxido de polialquileno, donde a) esta presente en una matriz de liberacion controlada que comprende b) y c).
CL2012002909A1 (es) Procedimiento de preparación de una composición farmacéutica que comprenden a) un centro granulado constituido por granos de principio activo aglomerados en presencia de aglomerante y b) una capa de recubrimiento de dicho centro granulado constituido por matriz grasa; composición farmacéutica; y su uso para administración oral
ES2543957T3 (es) Nueva composición farmacéutica para el tratamiento de infecciones fúngicas
CL2009001556A1 (es) Sistema de administración transdermica de fármacos que comprende una capa que contiene fármaco que comprende una matriz polimérica que contiene estradiol como unico fármaco; método de elaboración; útil para administrar estradiol.
MX2019007389A (es) Sistema terapeutico transdermico que contiene asenapina y polisiloxano o poliisobutileno.
CL2013000477A1 (es) Formulacion farmaceutica oral de liberacion inmediata que comprende nalbufina o una sal de la misma, y al menos, un soporte de granulacion hidrofilo, un aglutinante hidrofilo y un lubricante, util para el tratamiento del dolor y la dependencia a los opioides.
AR095672A1 (es) Composiciones farmacéuticas que comprenden everolimus
AR082640A1 (es) Un dispositivo para la administracion transdermal de compuestos alcalinos susceptibles a la degradacion en su forma no salificada
AR070031A1 (es) Sistemas de administracion transdermicos de droga ketotifen y metodos para el tratamiento de enfermedades oftalmicas
AR094289A1 (es) Sistemas de administracion transdermica de farmacos para levonorgestrel y etinil estradiol